Recombinant Human Papillomavirus Bivalent (Type 16/18) Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Papillomavirus Bivalent (Type 16/18) Vaccine, covering 2020-02-24 to 2020-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine [Phase 3]